STAAR Surgical Company (STAA)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

STAAR Surgical Company (STAA) is up 22.4% since the beginning of the year. At $28 per share, STAA is trading 21.2% below its 52-week high of $36. Investors who bought $1,000 worth of STAA shares 5 years ago would now be looking at an investment worth $206.

STAAR Surgical Company (STAA) has returned 22.39% so far this year and 64.88% over the past 12 months. Looking at the last ten years, STAA has achieved an annualized return of 17.36%, outperforming the S&P 500 Index benchmark, which averaged 13.66% per year.

Based on dividend-adjusted daily data since Mar 2, 1992, STAA's average daily return is +0.10%, while the average monthly return is +1.85%. At this rate, an investment would double in approximately 3.2 years.

Historically, 49% of months were positive and 51% were negative. The best month was Jun 2009 with a return of +143.4%, while the worst month was Mar 2001 at -52.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 8 months.

On a daily basis, STAA closed higher 45% of trading days. The best single day was Aug 12, 1992 with a return of +63.3%, while the worst single day was Sep 29, 2004 at -38.4%.

STAAR Surgical Company has an annualized alpha of 17.10%, beta of 0.91, and R2 of 0.06 versus S&P 500 Index. Calculated based on daily prices since March 03, 1992.

• This stock participated in 143.68% of S&P 500 Index downside but only 115.68% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.06 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

STAA ranks 73 for risk / return — better than 73% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for STAAR Surgical Company (STAA) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the STAAR Surgical Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the STAAR Surgical Company was 95.62%, occurring on May 1, 2009. Recovery took 1232 trading sessions.

The current STAAR Surgical Company drawdown is 82.63%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of STAAR Surgical Company over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how STAAR Surgical Company is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.